Nocturnal wandering caused by restless legs and short-acting benzodiazepines.
A patient with incapacitating restless-leg syndrome had suffered from repetitive confusional states exclusively after use of short-acting benzodiazepines. Complete removal of symptoms was achieved using levodopa. An association between many reported adverse reactions to triazolam and the common syndrome of restless legs or nocturnal myoclonus is suggested.
Lauerma
H
H
Remex Stress and Sleep Clinic, Turku, Finland.
D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001545:Benserazide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009207:Myoclonus / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D012148:Restless Legs Syndrome / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D012894:Sleep Stages / Q000187:drug effects; D013009:Somnambulism / Q000139:chemically induced* / Q000188:drug therapy; D014229:Triazolam / Q000008:administration & dosage / Q000009:adverse effects
D014151:Anti-Anxiety Agents; D014229:Triazolam; D007980:Levodopa; D001545:Benserazide